Public Statements

Limit results to:

Date Range

Keyword Search

Search string must be longer than 3 characters.

results per page:
Date Title Politician
Dec. 20, 2007 Finance Leaders Demand CMS Fix Serious and Systemic Contracting Deficiencies That Led tio Millions in Questionable Payments Sen. Chuck Grassley, ...
Dec. 18, 2007 Grassley, Schumer Push Proposals to Curb Abuse of Perfprmance-Enhancing Drugs Sen. Chuck Grassley, ...
Dec. 18, 2007 Statement of Senator Chuck Grassley on Steroid Use Sen. Chuck Grassley
Dec. 13, 2007 Mitchell Report on Major League Baseball Sen. Chuck Grassley
Nov. 20, 2007 Letter to Dr. Tadataka Yamada, Global Health Program President, Bill and Melinda Gates Foundation, Re: GlaxoSmithKline Drug Company Intimidation Case Sen. Chuck Grassley, ...
Nov. 20, 2007 Grassley, Baucus Resolution Designates November as National Meth Awareness Month Sen. Chuck Grassley
Nov. 15, 2007 Making Emergency Supplemental Appropriations Motion to Proceed Sen. Chuck Grassley
Nov. 14, 2007 Sen. Grassley Comments on New Black Box Warning for Heart Attcks on Widely Used Diabetes Drug Sen. Chuck Grassley
Nov. 13, 2007 Letter to FDA Commissioner Andrew von Eschenbach and CMS Acting Administrator Kerry Weems on the Marketing and Use of Unapproved Drugs Sen. Chuck Grassley
Nov. 7, 2007 Letter to Medicaid Acting Administrator Kerry Weems Requesting Information on Cancer Drugs and Other Medications Sen. Chuck Grassley
Nov. 7, 2007 Letter To Medicaid Acting Administrator Kerry Weems Requesting Information on Cancer Drugs and Other Medications Sen. Chuck Grassley
Nov. 7, 2007 National Methamphetamine Awareness Month Sen. Chuck Grassley
Oct. 31, 2007 Statements on Introduced Bills and Joint Resolutions Sen. Chuck Grassley
Oct. 30, 2007 Letter to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, U.S. Food and Drug Administration Sen. Chuck Grassley
Oct. 29, 2007 Letter to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, U.S. Food and Drug Administration Sen. Chuck Grassley
Oct. 24, 2007 Sen. Chuck Grassley Issued Comment About Warning Letter Sen. Chuck Grassley
Oct. 17, 2007 Red Ribbon Week Sen. Chuck Grassley
Oct. 16, 2007 Letter to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, U.S. Food and Drug Administration Sen. Chuck Grassley
Oct. 1, 2007 National Youth Antidrug Media Campaign Sen. Chuck Grassley
Sept. 27, 2007 Letter to Commissioner of FDA Re: Participant Protection in Clinical Drug Trials Sen. Chuck Grassley
Sept. 18, 2007 Hearing of the Senate Finance Committee : Methamphetamine Supply Chain Disruption Sen. Chuck Grassley
Sept. 18, 2007 Letter to the Chairmen and Ranking Members of the Senate Committee on Health, Education, Labor, and Pensions and the House Committee on Energy and Com Sen. Chuck Grassley
Sept. 12, 2007 Drug Safety Sen. Chuck Grassley
Sept. 11, 2007 Sen. Grassley Comments on Newly Released JAMA Articles and Commentary Regarding Avandia Sen. Chuck Grassley
Sept. 10, 2007 What are the on Answers: Disclosing Drug Industry Dollars to Doctors Sen. Chuck Grassley
Aug. 8, 2007 Letter to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, U.S. Food and Drug Administration Sen. Chuck Grassley
Aug. 3, 2007 Drug Abuse Sen. Chuck Grassley
Aug. 2, 2007 SCHIP Sen. Chuck Grassley
Aug. 2, 2007 Statements on Introduced Bills and Joint Resolutions Sen. Chuck Grassley
Aug. 2, 2007 Small Business Tax Relief Act of 2007 Sen. Chuck Grassley
July 31, 2007 FDA Panel Meeting on Avandia Sen. Chuck Grassley
July 26, 2007 FDA Legislation Sen. Chuck Grassley
July 24, 2007 Letter to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, Food and Drug Administration Sen. Chuck Grassley
July 13, 2007 Sen. Grassley Comments on the FDA Posting Information about Conflicts of Interest on Avandia Advisory Committee Sen. Chuck Grassley
July 13, 2007 Sen. Grassley Comments on the FDA Posting Information About Conflicts of Interest on Avandia Advisory Committee Sen. Chuck Grassley
June 11, 2007 Letter to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, Food and Drug Administration, Department of Health and Human Services Sen. Chuck Grassley, ...
June 7, 2007 Grassley Works to Stop Medicine Abuse Sen. Chuck Grassley
June 6, 2007 Grassley Asks FDA to Account for Its Response to Scientific Dissent on Safety of Avandia Sen. Chuck Grassley
June 6, 2007 Senators Ask for Details of Effort to Muzzle a Doctor's Concern About Avandia Risks Sen. Chuck Grassley
May 30, 2007 Grassley Seeks Additional Information About Pricing and Marketing of Anti-Anemia Drugs Sen. Chuck Grassley
May 25, 2007 Grassley, Baucus Bill Would Enhance Research on Pharmaceutical Safety and Effectiveness Sen. Chuck Grassley
May 24, 2007 Statements on Introduced Bills and Joint Resolutions Sen. Chuck Grassley
May 24, 2007 Safety of Avandia Sen. Chuck Grassley
May 22, 2007 Avandia and the FDA Sen. Chuck Grassley
May 21, 2007 Letter to the FDA and Letter to GlaxoSmithKline Sen. Chuck Grassley, ...
May 21, 2007 Safety of Avandia Sen. Chuck Grassley
May 16, 2007 Sen. Grassley Seeks to Empower FDA to Access Drug-Risk Information From Drug Makers Sen. Chuck Grassley
May 16, 2007 CADCA Newsletter - Generation Rx: Teens' Recreational Use of Prescription and Over-the-Counter Drugs Requires Community Action Sen. Chuck Grassley, ...
May 16, 2007 Grassley Seeks to Empower FDA to Access Drug-risk Information from Drug Makers Sen. Chuck Grassley
May 9, 2007 Grassley Wins Senate Passage of Amendment to Strengthen New FDA Authority Sen. Chuck Grassley
May 9, 2007 Prescription Drug User Fee Amendments of 2007 Sen. Chuck Grassley
May 8, 2007 Hearing of the Senate Finance Committee on "The Medicare Prescription Drug Benefit: Review and Oversight" Sen. Chuck Grassley
May 7, 2007 Prescription Drug User Fee Amendments of 2007 Sen. Chuck Grassley
May 7, 2007 Amendents to the Food and Drug Administration Revitalization Act Sen. Chuck Grassley
May 3, 2007 Prescription Drug User Fee Amendments of 2007 Sen. Chuck Grassley
May 3, 2007 Statements on Introduced Bills and Joint Resolutions Sen. Chuck Grassley
May 2, 2007 Hearing of the Senate Finance Committee on "The Medicare Prescription Drug Benefit: Monitoring Early Experiences" Sen. Chuck Grassley
May 2, 2007 Prescription Drug User Fee Amendments of 2007 Sen. Chuck Grassley
May 1, 2007 Grassley: It Should be Legal to Buy Cheaper Prescription Drugs from Other Countries Sen. Chuck Grassley
May 1, 2007 Time to End Sweetheart Deals Between Brand-Name and Generic Drug Manufactures Sen. Chuck Grassley
April 25, 2007 New Finance Committee Report Focuses on Drug Company Grants for Medical Education Sen. Chuck Grassley
April 25, 2007 Statements on Introduced Bills and Joint Resolutions Sen. Chuck Grassley
April 25, 2007 Letter to Murray Kopelow, MD, MSC, FRCPC, Chief Executive, Accreditation Council for Continuing Medical Education Sen. Chuck Grassley, ...
April 18, 2007 Prescription Drugs Sen. Chuck Grassley
April 18, 2007 Drug Safety Sen. Chuck Grassley
April 17, 2007 Intelligence Authorization Act for Fiscal Year 2007--Continued Sen. Chuck Grassley
April 16, 2007 Prescription Drug Safety Consumer Reports Poll Sen. Chuck Grassley
April 13, 2007 Hearing of the Senate Committee on Finance on Mark-Up of S.3, the Medicare Prescription Drug Price Negotiation Act of 2007 Sen. Chuck Grassley
April 11, 2007 CBO Repeats: Government Interference with Medicare Drug Prices Won't Work Sen. Chuck Grassley
March 20, 2007 Sen. Grassley Urges FDA to Educate and Inform Public About Acetaminophen Sen. Chuck Grassley
March 12, 2007 Grassley Says FDA Problems Need Sunshine, Calls on Commissioner to Reverse Chill Factor Sen. Chuck Grassley
March 8, 2007 Hearing of the Senate Judiciary Subcommittee on Agriculture Concentration and Generic Drugs Sen. Chuck Grassley
March 6, 2007 Baucus, Grassley Ask FDA to Account for Findings of New Report Sen. Chuck Grassley
March 2, 2007 Rx Prices, Choices for Consumers Sen. Chuck Grassley
Feb. 13, 2007 House of Representatives Committee on Energy and Commerce on The Adequacy of FDA Efforts to Assure the Safety of the Drug Supply Sen. Chuck Grassley
Date Title Politician
Dec. 20, 2007 Finance Leaders Demand CMS Fix Serious and Systemic Contracting Deficiencies That Led tio Millions in Questionable Payments Sen.Chuck Grassley, ...
Dec. 18, 2007 Grassley, Schumer Push Proposals to Curb Abuse of Perfprmance-Enhancing Drugs Sen.Chuck Grassley, ...
Dec. 18, 2007 Statement of Senator Chuck Grassley on Steroid Use Sen.Chuck Grassley
Dec. 13, 2007 Mitchell Report on Major League Baseball Sen.Chuck Grassley
Nov. 20, 2007 Letter to Dr. Tadataka Yamada, Global Health Program President, Bill and Melinda Gates Foundation, Re: GlaxoSmithKline Drug Company Intimidation Case Sen.Chuck Grassley, ...
Nov. 20, 2007 Grassley, Baucus Resolution Designates November as National Meth Awareness Month Sen.Chuck Grassley
Nov. 15, 2007 Making Emergency Supplemental Appropriations Motion to Proceed Sen.Chuck Grassley
Nov. 14, 2007 Sen. Grassley Comments on New Black Box Warning for Heart Attcks on Widely Used Diabetes Drug Sen.Chuck Grassley
Nov. 13, 2007 Letter to FDA Commissioner Andrew von Eschenbach and CMS Acting Administrator Kerry Weems on the Marketing and Use of Unapproved Drugs Sen.Chuck Grassley
Nov. 7, 2007 Letter to Medicaid Acting Administrator Kerry Weems Requesting Information on Cancer Drugs and Other Medications Sen.Chuck Grassley
Nov. 7, 2007 Letter To Medicaid Acting Administrator Kerry Weems Requesting Information on Cancer Drugs and Other Medications Sen.Chuck Grassley
Nov. 7, 2007 National Methamphetamine Awareness Month Sen.Chuck Grassley
Oct. 31, 2007 Statements on Introduced Bills and Joint Resolutions Sen.Chuck Grassley
Oct. 30, 2007 Letter to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, U.S. Food and Drug Administration Sen.Chuck Grassley
Oct. 29, 2007 Letter to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, U.S. Food and Drug Administration Sen.Chuck Grassley
Oct. 24, 2007 Sen. Chuck Grassley Issued Comment About Warning Letter Sen.Chuck Grassley
Oct. 17, 2007 Red Ribbon Week Sen.Chuck Grassley
Oct. 16, 2007 Letter to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, U.S. Food and Drug Administration Sen.Chuck Grassley
Oct. 1, 2007 National Youth Antidrug Media Campaign Sen.Chuck Grassley
Sept. 27, 2007 Letter to Commissioner of FDA Re: Participant Protection in Clinical Drug Trials Sen.Chuck Grassley
Sept. 18, 2007 Hearing of the Senate Finance Committee : Methamphetamine Supply Chain Disruption Sen.Chuck Grassley
Sept. 18, 2007 Letter to the Chairmen and Ranking Members of the Senate Committee on Health, Education, Labor, and Pensions and the House Committee on Energy and Com Sen.Chuck Grassley
Sept. 12, 2007 Drug Safety Sen.Chuck Grassley
Sept. 11, 2007 Sen. Grassley Comments on Newly Released JAMA Articles and Commentary Regarding Avandia Sen.Chuck Grassley
Sept. 10, 2007 What are the on Answers: Disclosing Drug Industry Dollars to Doctors Sen.Chuck Grassley
Aug. 8, 2007 Letter to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, U.S. Food and Drug Administration Sen.Chuck Grassley
Aug. 3, 2007 Drug Abuse Sen.Chuck Grassley
Aug. 2, 2007 SCHIP Sen.Chuck Grassley
Aug. 2, 2007 Statements on Introduced Bills and Joint Resolutions Sen.Chuck Grassley
Aug. 2, 2007 Small Business Tax Relief Act of 2007 Sen.Chuck Grassley
July 31, 2007 FDA Panel Meeting on Avandia Sen.Chuck Grassley
July 26, 2007 FDA Legislation Sen.Chuck Grassley
July 24, 2007 Letter to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, Food and Drug Administration Sen.Chuck Grassley
July 13, 2007 Sen. Grassley Comments on the FDA Posting Information about Conflicts of Interest on Avandia Advisory Committee Sen.Chuck Grassley
July 13, 2007 Sen. Grassley Comments on the FDA Posting Information About Conflicts of Interest on Avandia Advisory Committee Sen.Chuck Grassley
June 11, 2007 Letter to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, Food and Drug Administration, Department of Health and Human Services Sen.Chuck Grassley, ...
June 7, 2007 Grassley Works to Stop Medicine Abuse Sen.Chuck Grassley
June 6, 2007 Grassley Asks FDA to Account for Its Response to Scientific Dissent on Safety of Avandia Sen.Chuck Grassley
June 6, 2007 Senators Ask for Details of Effort to Muzzle a Doctor's Concern About Avandia Risks Sen.Chuck Grassley
May 30, 2007 Grassley Seeks Additional Information About Pricing and Marketing of Anti-Anemia Drugs Sen.Chuck Grassley
May 25, 2007 Grassley, Baucus Bill Would Enhance Research on Pharmaceutical Safety and Effectiveness Sen.Chuck Grassley
May 24, 2007 Statements on Introduced Bills and Joint Resolutions Sen.Chuck Grassley
May 24, 2007 Safety of Avandia Sen.Chuck Grassley
May 22, 2007 Avandia and the FDA Sen.Chuck Grassley
May 21, 2007 Letter to the FDA and Letter to GlaxoSmithKline Sen.Chuck Grassley, ...
May 21, 2007 Safety of Avandia Sen.Chuck Grassley
May 16, 2007 Sen. Grassley Seeks to Empower FDA to Access Drug-Risk Information From Drug Makers Sen.Chuck Grassley
May 16, 2007 CADCA Newsletter - Generation Rx: Teens' Recreational Use of Prescription and Over-the-Counter Drugs Requires Community Action Sen.Chuck Grassley, ...
May 16, 2007 Grassley Seeks to Empower FDA to Access Drug-risk Information from Drug Makers Sen.Chuck Grassley
May 9, 2007 Grassley Wins Senate Passage of Amendment to Strengthen New FDA Authority Sen.Chuck Grassley
May 9, 2007 Prescription Drug User Fee Amendments of 2007 Sen.Chuck Grassley
May 8, 2007 Hearing of the Senate Finance Committee on "The Medicare Prescription Drug Benefit: Review and Oversight" Sen.Chuck Grassley
May 7, 2007 Prescription Drug User Fee Amendments of 2007 Sen.Chuck Grassley
May 7, 2007 Amendents to the Food and Drug Administration Revitalization Act Sen.Chuck Grassley
May 3, 2007 Prescription Drug User Fee Amendments of 2007 Sen.Chuck Grassley
May 3, 2007 Statements on Introduced Bills and Joint Resolutions Sen.Chuck Grassley
May 2, 2007 Hearing of the Senate Finance Committee on "The Medicare Prescription Drug Benefit: Monitoring Early Experiences" Sen.Chuck Grassley
May 2, 2007 Prescription Drug User Fee Amendments of 2007 Sen.Chuck Grassley
May 1, 2007 Grassley: It Should be Legal to Buy Cheaper Prescription Drugs from Other Countries Sen.Chuck Grassley
May 1, 2007 Time to End Sweetheart Deals Between Brand-Name and Generic Drug Manufactures Sen.Chuck Grassley
April 25, 2007 New Finance Committee Report Focuses on Drug Company Grants for Medical Education Sen.Chuck Grassley
April 25, 2007 Statements on Introduced Bills and Joint Resolutions Sen.Chuck Grassley
April 25, 2007 Letter to Murray Kopelow, MD, MSC, FRCPC, Chief Executive, Accreditation Council for Continuing Medical Education Sen.Chuck Grassley, ...
April 18, 2007 Prescription Drugs Sen.Chuck Grassley
April 18, 2007 Drug Safety Sen.Chuck Grassley
April 17, 2007 Intelligence Authorization Act for Fiscal Year 2007--Continued Sen.Chuck Grassley
April 16, 2007 Prescription Drug Safety Consumer Reports Poll Sen.Chuck Grassley
April 13, 2007 Hearing of the Senate Committee on Finance on Mark-Up of S.3, the Medicare Prescription Drug Price Negotiation Act of 2007 Sen.Chuck Grassley
April 11, 2007 CBO Repeats: Government Interference with Medicare Drug Prices Won't Work Sen.Chuck Grassley
March 20, 2007 Sen. Grassley Urges FDA to Educate and Inform Public About Acetaminophen Sen.Chuck Grassley
March 12, 2007 Grassley Says FDA Problems Need Sunshine, Calls on Commissioner to Reverse Chill Factor Sen.Chuck Grassley
March 8, 2007 Hearing of the Senate Judiciary Subcommittee on Agriculture Concentration and Generic Drugs Sen.Chuck Grassley
March 6, 2007 Baucus, Grassley Ask FDA to Account for Findings of New Report Sen.Chuck Grassley
March 2, 2007 Rx Prices, Choices for Consumers Sen.Chuck Grassley
Feb. 13, 2007 House of Representatives Committee on Energy and Commerce on The Adequacy of FDA Efforts to Assure the Safety of the Drug Supply Sen.Chuck Grassley
arrow_upward